Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Quantification and Proximal-to-Distal Distribution Pattern of Tibial Nerve Lesions in Relapsing-Remitting Multiple Sclerosis : Assessment by MR Neurography.
Pietsch AM, Viehöver A, Diem R, Weiler M, Korporal-Kuhnke M, Wildemann B, Sam G, Hayes JM, Fösleitner O, Jende JME, Heiland S, Bendszus M, Hayes JC. Pietsch AM, et al. Among authors: viehover a. Clin Neuroradiol. 2023 Jun;33(2):383-392. doi: 10.1007/s00062-022-01219-1. Epub 2022 Oct 20. Clin Neuroradiol. 2023. PMID: 36264352 Free PMC article.
Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis.
Haas J, Hug A, Viehöver A, Fritzsching B, Falk CS, Filser A, Vetter T, Milkova L, Korporal M, Fritz B, Storch-Hagenlocher B, Krammer PH, Suri-Payer E, Wildemann B. Haas J, et al. Among authors: viehover a. Eur J Immunol. 2005 Nov;35(11):3343-52. doi: 10.1002/eji.200526065. Eur J Immunol. 2005. PMID: 16206232 Free article.
Failure of alemtuzumab therapy to control MOG encephalomyelitis.
Wildemann B, Jarius S, Schwarz A, Diem R, Viehöver A, Hähnel S, Reindl M, Korporal-Kuhnke M. Wildemann B, et al. Among authors: viehover a. Neurology. 2017 Jul 11;89(2):207-209. doi: 10.1212/WNL.0000000000004087. Epub 2017 Jun 9. Neurology. 2017. PMID: 28600462 No abstract available.
Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity.
Ostkamp P, Salmen A, Pignolet B, Görlich D, Andlauer TFM, Schulte-Mecklenbeck A, Gonzalez-Escamilla G, Bucciarelli F, Gennero I, Breuer J, Antony G, Schneider-Hohendorf T, Mykicki N, Bayas A, Then Bergh F, Bittner S, Hartung HP, Friese MA, Linker RA, Luessi F, Lehmann-Horn K, Mühlau M, Paul F, Stangel M, Tackenberg B, Tumani H, Warnke C, Weber F, Wildemann B, Zettl UK, Ziemann U, Müller-Myhsok B, Kümpfel T, Klotz L, Meuth SG, Zipp F, Hemmer B, Hohlfeld R, Brassat D, Gold R, Gross CC, Lukas C, Groppa S, Loser K, Wiendl H, Schwab N; German Competence Network Multiple Sclerosis (KKNMS) and the BIONAT Network. Ostkamp P, et al. Proc Natl Acad Sci U S A. 2021 Jan 5;118(1):e2018457118. doi: 10.1073/pnas.2018457118. Proc Natl Acad Sci U S A. 2021. PMID: 33376202 Free PMC article.
COVID-19-related severe MS exacerbation with life-threatening Takotsubo cardiomyopathy in a previously stable patient and interference of MS therapy with long-term immunity against SARS-CoV-2.
Wildemann B, Jarius S, Lehmann LH, André F, Frey N, Schnitzler P, Jäger L, Gumbinger C, Viehöver A. Wildemann B, et al. Among authors: viehover a. J Neurol. 2022 Mar;269(3):1138-1141. doi: 10.1007/s00415-021-10779-0. Epub 2021 Oct 7. J Neurol. 2022. PMID: 34617145 Free PMC article. No abstract available.
Improving the sensitivity of myelin oligodendrocyte glycoprotein-antibody testing: exclusive or predominant MOG-IgG3 seropositivity-a potential diagnostic pitfall in patients with MOG-EM/MOGAD.
Jarius S, Ringelstein M, Schanda K, Ruprecht K, Korporal-Kuhnke M, Viehöver A, Hümmert MW, Schindler P, Endmayr V, Gastaldi M, Trebst C, Franciotta D, Aktas O, Höftberger R, Haas J, Komorowski L, Paul F, Reindl M, Wildemann B. Jarius S, et al. Among authors: viehover a. J Neurol. 2024 Jul;271(7):4660-4671. doi: 10.1007/s00415-024-12285-5. Epub 2024 Apr 13. J Neurol. 2024. PMID: 38609667 Free PMC article.
Quality Assessment in Multiple Sclerosis Therapy (QUASIMS): a comparison of interferon beta therapies for relapsing-remitting multiple sclerosis.
Limmroth V, Malessa R, Zettl UK, Koehler J, Japp G, Haller P, Elias W, Obhof W, Viehöver A, Meier U, Brosig A, Hasford J, Putzki N, Kalski G, Wernsdörfer C; QUASIMS Study Group. Limmroth V, et al. Among authors: viehover a. J Neurol. 2007 Jan;254(1):67-77. doi: 10.1007/s00415-006-0281-1. Epub 2007 Feb 1. J Neurol. 2007. PMID: 17273808 Clinical Trial.
18 results